Trump Administration goes After Medical Marijuana – Threat to Prescription Opioid Drug Sales?

As soon as President Trump announced his Attorney General (AG) appointee as Senator Jeff Sessions from Alabama, there was tension among medical cannabis advocates. Would Trump honor his campaign comments about state’s rights regarding medical marijuana, or would his new Attorney General be unleashed to increase the war on drugs using cannabis as his first target? Unfortunately, Trump’s Attorney General appointee Jeff Sessions has been quoted as saying heroin is only slightly worse than marijuana and "good people don’t smoke marijuana." And as the United States Attorney General, he is head of the Department of Justice (DOJ), which houses the Drug Enforcement Administration (DEA). News reports this week revealed a letter Sessions sent to Congress last month seeking funding to go after medical cannabis operations in states where medical marijuana is legal. “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” Sessions wrote in a letter to Republican and Democratic House and Senate leadership. “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.” Sessions reasons for going after medical cannabis were quickly exposed as false by many in the media. Washington Post’s Christopher Ingraham wrote: Sessions’s citing of a “historic drug epidemic” to justify a crackdown on medical marijuana is at odds with what researchers know about current drug use and abuse in the United States. The epidemic Sessions refers to involves deadly opiate drugs, not marijuana. A growing body of research (acknowledged by the National Institute on Drug Abuse) has shown that opiate deaths and overdoses actually decrease in states with medical marijuana laws on the books. With the well-known national epidemic of opioid prescription drug abuse spiraling out of control, and medical marijuana's documented evidence of reducing opioid addiction, one has to wonder if the pharmaceutical drug manufacturers are behind this new emphasis to go after medical marijuana? Is medical marijuana a threat to their legal opioid drug sales?

Profitable Opioid Painkillers and Synthetic Pot Patents: Big Pharma’s Motivation to Keep Marijuana Illegal

Last year’s November elections included several state ballots to either introduce medical marijuana or expand beyond permissible medical applications and allow “recreational” use for adults. Former marijuana resistant states Florida, North Dakota, Arkansas, and Montana passed medical cannabis measures by popular vote. States that had medical marijuana allowances already in place, California, Massachusetts, Nevada, and Maine approved adult recreational marijuana. But the biggest surprise for many was Arizona voters' rejection of an adult recreational use measure, Proposition 205. Arizona was the only state that refused to advance from its current cannabis status at the polls. Arizonians for Responsible Drug Policy (ARDP) was the major front group for hire that publicly opposed Arizona's Proposition 205. And its main donor of a half million dollars was a pharmaceutical company based out of Arizona known as Insys Therapeutics. Was Insys Therapeutics' motivation to oppose legal marijuana its lucrative opioid painkiller market, or its recent approval for a patent to make a synthetic form of marijuana?

New Bills Proposed to Protect Consumer Access to Medical Marijuana Extract

Two bills have been introduced to protect consumer access to cannabidiol (CBD). We have a growing opioid painkiller epidemic in this country—one that has followed the scandal of so many heart-health-destroying or cancer-causing pain relievers being approved by the FDA. There is a natural alternative, and of course the government is intent on banning it for no reason at all—other than to clear the way for a blockbuster new drug. Rep. Morgan Griffith (R-VA) has introduced two bills, the Legitimate Use of Medical Marijuana Act (HR 714) and the Compassionate Access Act (HR 715), both aimed at removing federal obstacles that prevent patient access to CBD, a medicinal extract of the marijuana plant. These bills follow a recent move by the Drug Enforcement Agency (DEA) that classified marijuana and all its extracts as Schedule I controlled substances—a category that includes heroin, LSD, mescaline, and MDMA. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana—only the non-psychoactive painkilling chemicals. Although “CBD” or “cannibinoids” are not mentioned in the Controlled Substances Act (CSA)—the legislation that the DEA must follow in creating rules related to controlled substances—the agency nonetheless lumps CBD and all other constituents of the plant into the definition of “marijuana.”

Children Taken from Military Dad Using Medical Marijuana for PTSD to be Returned

Tuesday, December 13th, was a day of victory for the Schwab family, and their advocate Jennifer Winn is calling it "a miracle." When Raymond and Amelia Schwab walked into the Riley County Courthouse in Kansas Tuesday morning, it looked like they were going to lose their children. Child Protective Services' social workers had made it clear that they were pushing for termination of parental rights during the 3 day permanency hearing. Instead, the judge ruled that there will be no termination, but instead, they are to be reunified with their children. Raymond Schwab told Health Impact News: "They really were attempting to terminate, and they failed." It has been 18 long months since 5 of their 6 children were first seized by Kansas Department for Children and Families (DCF) over false allegations. (Their oldest was already of age.) Raymond, a Navy Gulf War veteran, went on a hunger strike last spring in the hopes of getting his children home. Like many military veterans, Raymond suffered from Post Traumatic Stress Disorder (PTSD), and when pharmaceutical products were used to treat his symptoms, he developed a heroin addiction. He was prescribed medical marijuana to break his heroin addiction, and the family was living in Colorado homeschooling their children where medical marijuana is legal. The family was happy, and Raymond had successfully returned to the work force. But while visiting Kansas where marijuana is not legal, false allegations led to CPS taking custody of their children. The Schwab family case gained national media attention over the civil rights of military veterans and medical marijuana users.

Opioid Pain Killer Drug Addictions Can Be Cured With Cannabis

The heroin and opioid painkiller overuse, addiction, and resulting death toll that averages out to 78 deaths per day has become an epidemic that continues to grow, except in states that have liberal medical marijuana laws. The CDC concedes that at least half of those statistics are fueled by opioid painkiller prescriptions of Oxycodone, as used in OxyContin®, Hydrocodone, with Vicodin® for example, and Methadone, ironically often prescribed under several brand names to assist those withdrawing from heroine. Those addicted to opioids are now taking advantage of medical marijuana legalization and using cannabis for pain instead of opioids.

Obama Adminstration’s DEA Ignores Marijuana Therapeutic Research – Keeps Status Illegal to Protect Big Pharma

The recent 2016 DEA decision to keep cannabis as a controlled substance Schedule I drug came amidst high hopes that it would be placed as Schedule II or below. Schedule I means the substance is dangerous, addictive, and has no medical merit. Marijuana or cannabis is therefore still ranked with heroin, and LSD. Heroin is an addictive and dangerous opiate that in other opioid forms such as morphine is used to suppress pain with legal prescriptions. Yet on the federal level, doctors cannot prescribe marijuana, in spite of so much evidence of its therapeutic value. At the same time, however, in what appears as an obvious hypocritical move that benefits only Big Pharma, the DEA, while not removing the criminal legal status on marijuana, did relax the laws regarding medical research on marijuana which will soon benefit drug companies looking to patent drugs that mimic what the plant already does.

Cannabis Treats Diabetes and Protects Against Obesity

How counter-intuitive can one get? Everybody knows marijuana users get the “munchies,” which are usually satisfied with high calorie low nutrient foods. It's also somewhat accepted by mainstream oncology that cannabis curbs chemo patients' nausea and boosts their appetites. Yet studies demonstrate that even recreational pot users have a considerably lower incidence of obesity and metabolic syndrome, which often leads to diabetes 2. These published peer reviewed studies are a small sampling of international studies from Israel, Spain, Italy, and the USA among others that have looked into various applications of cannabis for treatments for other diseases with positive results. Yet, the DEA Controlled Substance Schedule 1 rating for cannabis of dangerous, addictive, and without medical merit stands as of this writing. Apparently, the Justice Department that governs the DEA is trying to protect the pharmaceutical industry, not ordinary citizens.

How People are Healing Serious Gut Disease with Cannabis That Mainstream Medicine Has Nothing to Offer

There have been several anecdotal reports of cannabis curing cancer. But less discussion has been publicized about cannabis curing Crohn's disease and other inflammatory bowel and gut diseases that are considered incurable by mainstream medicine. Perhaps the most dramatic story has a woman named Shona Banda at its center. Shona was severely stricken with Crohn's. She was bedridden, and whatever she managed to eat didn’t provide nutrition because her gastrointestinal tract simply wouldn’t absorb nutrients

Cannabis Remedies for Epilepsy Were Discovered and Buried in the 1940s

Applying low THC high CBD cannabis or cannabidiol successfully for seizures has become relatively widespread among families with children who are having chronic seizures, even several grand mal seizures daily. This awareness was greatly enhanced by an unusual mainstream August 2013 media report by CNN's Dr. Sanjay Gupta, M.D., called “Weed.” Since that report, high CBD (cannabidiol) low THC (Tetrahydrocannabinol), the psychoactive compound of cannabis, is being used successfully for children with terminal seizures throughout the nation. Harken back to the days of former alcohol prohibitionist Harry Anslinger who was appointed head of The Bureau of Narcotics, formed around the time of the 1937 Marijuana Tax Act. You may be surprised to find that in 1947, a similar study was underway for using a synthetic form of THC with at least 50% success rate for children with intractable seizure issues. Anslinger and company did what they could do to prevent the news from getting out. But the study papers slipped through and were recently discovered. Let's explore what could have existed for 66 years as relief from the ever increasing numbers of seizure stricken children, which corresponds with the increased CDC childhood vaccine schedule.

Medical Cannabis is Healing Autism

The subject of autism and its causes is getting more attention due to the documentary Vaxxed. It's like a continual road show going from city to city with its crew of key personnel conducting panel discussions after showings. That's great and sorely needed. But there's little awareness promoted for treating autism among the vaccine damaged. The Cannabis Summit revealed several medical practitioners of different stripes who are willing and able to use cannabis in their practices. One of them was Dr. Bogner who presented on the topic “New Frontier on Autism Spectrum Disorder Recovery: Medical Marijuana."